에 대한 최신 뉴스 BlackLine (NASDAQ:BL) 주식

BLACKLINE INC

BlackLine

BlackLine Inc is engaged in providing financial accounting close solutions delivered as Software as a Service (SaaS). The Company's solutions enable its customers to address various aspects of their critical processes, including financial close & consolidation, intercompany accounting, and invoice-to-cash. The majority of the revenue of the company is earned in the United States.

stock chart-1863880_1920-60

News

BILL

ETSY

ICLR

MTCH

SDRL

엘리엇 인베스트먼트 매니지먼트(Elliott Investment Management)는 3분기에 분주했다. 미 증권거래위원회(SEC)에 새로 제출한 13-F에 따르면 이 행동주의 투자자는 여행 및 숙박에 초점을 맞춘 여러 가지 새로운 포지션을 포함하여 여러 가지 포트폴리오 전환을 수행했다.

엘리엇이 3분기에 웨스턴 디지털, 엣시는 추가; 씨드릴, 블랙라인, NRG 에너지는 축소

BlackLine Inc

BELLEVUE LIFE SCIENCES ACQUISITION CORP COM

BELLEVUE LIFE SCIENCES ACQUISITION CORP RT

BELLEVUE LIFE SCIENCES ACQUISITION CORP UNIT 1 COM & 1 WT & 1 RT EXP

BELLEVUE LIFE SCIENCES ACQUISITION CORP WT EXP

BLUE LAGOON RESOURCES INC by Blue Lagoon Resources Inc.

Blue Lagoon Resources Inc

BlockWallet

Blast - United States Dollar

Blue Bird Corp

Bilibili Inc

BLOOMBERRY RESORTS CORP by Bloomberry Resorts Corp

Bloomberry Resorts Corp

Blackboxstocks Inc

Black Cat Syndicate Ltd

Bellicum Pharmaceuticals Inc

Siren Nasdaq NexGen Economy ETF

Bausch & Lomb Corp

iShares Large Cap Core Active ETF

Bloomzed Loyalty Club Ticket

iShares Large Cap Value Active ETF

TopBuild Corp

Blade Air Mobility, Inc. - Class A Common Stock

Blade Air Mobility Inc

Cambria Global Real Estate ETF

Ballard Power Systems, Inc. - Common Shares

Ballard Power Systems Inc

Builders FirstSource Inc

BLUE DIAMOND VENTURES INC by Blue Diamond Ventures, Inc.

Blue Diamond Ventures Inc

Blackrock Municipal Income Trust II

BRANDED LEGACY INC by BRANDED LEGACY INC.

Branded Legacy Inc

Inspire Global Hope ETF

Bleuacacia Ltd

BLEUACACIA LTD RT

Bleuacacia Ltd Units (1 Ord Share Class A &1Right & 1/2 War)

BELEAVE INC ORD by Beleave Inc.

BALFOUR BEATTY PLC U/ADR by Balfour Beatty Plc

Balfour Beatty PLC

BIOLIFE SCIENCES INC by BIOLIFE SCIENCES INC.

Biolife Sciences Inc

BLUEFIRE EQUIPMENT CORP by BlueFire Equipment Corp.

BlueFire Equipment Corp

BioLife Solutions Inc

Blue Foundry Bancorp

BULIGO CAPITAL LTD by BULIGO CAPITAL LTD.

BAILLIE GIFFORD US GROWTH by BAILLIE GIFFORD US GROWTH TR PLC

BLGI Inc

BioLargo Inc

BELGRAVIA HARTFORD INC by BELGRAVIA HARTFORD CAP INC.

Belgravia Hartford Capital Inc

BALOISE HLDGS BASEL NAMEN by Baloise Holdings AG

Baloise Holding AG

BALOISE HLDGS UNSP/ADR by Baloise Holdings AG

BLUE HOLDINGS INC by Blue Holdings, Inc.

BLUEHARBOR BANK (NC) by BlueHarbor Bank (Mooresville NC)

BlueHarbor Bank

BELIMO HOLDINGS AG NEW by Belimo Holding AG

Belimo Holding AG

BB LIQUIDATING INC A by BB Liquidating Inc.

BB Liquidating Inc

BB LIQUIDATING INC B by BB Liquidating Inc.

Boliden AB

Bridgeline Digital Inc

NAPC Defense Inc

i3 Interactive Inc

BeLive Holdings

BERLI JUCKER PCL UNSP/ADR by Berli Jucker Public Co., Ltd.

Berli Jucker PCL

BlackRock Inc

Blackbaud Inc

Invesco Alerian Galaxy Blockchain Users and Decentralized Commerce ETF

GLOBAL GAMING TECHS by Global Gaming Technologies Corp.

Global Gaming Technologies Corp

BUILD KING HLDGS LTD by Build King Holdings, Ltd.

Build King Holdings Ltd

BLACKLINE SAFETY CORP by Blackline Safety Corp

Blackline Safety Corp

BLACKWELL INTELLIGNCE INC by BLACKWELL INTELLIGENCE INC

Blackwell Intelligence Inc

BELL BUCKLE HLDGS INC by Bell Buckle Holdings, Inc.

Bell Buckle Holdings Inc

JPMorgan Exchange-Traded Fund Trust Sustainable Infrastructure ETF

BELL INDUSTRIES INC by Bell Industries, Inc.

BELL EQUIPMENT LTD ORD by Bell Equipment Ltd.

Bell Equipment Ltd

BIOLIGHT LIFE SCIENCE LTD by BioLight Life Sciences Ltd.

BioLight Life Sciences Ltd

BULLET EXPLORATION INC by BULLET EXPLORATION INC.

80 Mile PLC

BILOXI MARSH LANDS CORP by Biloxi Marsh Lands Corp.

Biloxi Marsh Lands Corp

Blum Holdings Inc

Bloom Health Partners Inc Ordinary Shares

BANK LEUMI LE ISRAEL by Bank Leumi Le Israel

Bank Leumi Le-Israel BM

Bloomin Brands Inc

Bloomios Inc

BALMUDA INC by BALMUDA INC

BLUMETRIC ENVIRONMNTL INC by BluMetric Environmental, Inc.

BluMetric Environmental Inc

BloomZ Inc

Balance Labs Inc

Blend Labs Inc

Beeline Holdings Inc

Blink Charging Co

BLUE NOTE MINING INC NEW by Blue Note Mining Inc.

Blue Note Mining Inc

Blocknet

Amplify Transformational Data Sharing ETF

Bloktopia

CO2 Gro Inc

CANNABIX TECHS INC ORD by Cannabix Technologies Inc.

Cannabix Technologies Inc

BullPerks

BLOK TECHNOLOGIES INC by Blok Technologies Inc.

BLOK Technologies Inc

BLUE LINE PROTECTION GRP by Blue Line Protection Group, Inc.

Blue Line Protection Group Inc

Bellerophon Therapeutics Inc Com (New)

BlockQuarry Corp

Billerud AB

Faraday Future (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFAI#NASDAQ">FFAI</a>) reported quarterly losses of $(0.14) per share. This is a 99.47 percent increase over losses of $(26.23) per share from the same period last year. The company reported $316.00 thousand in sales this quarter. This is a 15.70K percent increase over sales of $2.00 thousand the same period last year.

Earnings

Faraday Future Intelligent Electric Inc. - Class A Common Stock

FFAI

Reported May 8, 2025: Faraday Future Q1 EPS $(0.14) Up From $(26.23) YoY, Sales $316.00K Up From $2.00K YoY

Guidewire Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>) has outperformed the market over the past 10 years by 5.35% on an annualized basis producing an average annual return of 15.62%. Currently, Guidewire Software has a market capitalization of $17.91 billion. 
Buying $100 In GWRE: If an investor had bought $100 of GWRE stock 10 years ago, it would be worth $411.90 today based on a price of $213.57 for GWRE at the time of writing.
<h3>Guidewire Software's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746832511_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

GWRE

$100 Invested In Guidewire Software 10 Years Ago Would Be Worth This Much Today

Chardan Capital analyst Geulah Livshits maintains Rocket Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCKT#NASDAQ">RCKT</a>) with a Buy and lowers the price target from $54 to $45.

Price Target

Analyst Ratings

RCKT

Chardan Capital Maintains Buy on Rocket Pharmaceuticals, Lowers Price Target to $45

Chardan Capital analyst Geulah Livshits maintains 4D Molecular Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FDMT#NASDAQ">FDMT</a>) with a Buy and lowers the price target from $28 to $25.

FDMT

Chardan Capital Maintains Buy on 4D Molecular Therapeutics, Lowers Price Target to $25

UBS analyst Trung Huynh maintains Celldex Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLDX#NASDAQ">CLDX</a>) with a Buy and lowers the price target from $44 to $38.

CLDX

UBS Maintains Buy on Celldex Therapeutics, Lowers Price Target to $38

Domino's Pizza (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NASDAQ">DPZ</a>) has outperformed the market over the past 20 years by 8.79% on an annualized basis producing an average annual return of 16.95%. Currently, Domino's Pizza has a market capitalization of $16.40 billion. 
Buying $1000 In DPZ: If an investor had bought $1000 of DPZ stock 20 years ago, it would be worth $22,913.88 today based on a price of $478.90 for DPZ at the time of writing.
<h3>Domino's Pizza's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746829811_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Domino's Pizza 20 Years Ago Would Be Worth Today

UBS analyst Christopher Schoell maintains Cogent Comms Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCOI#NASDAQ">CCOI</a>) with a Buy and lowers the price target from $102 to $75.

CCOI

UBS Maintains Buy on Cogent Comms Hldgs, Lowers Price Target to $75

UBS analyst Josh Silverstein maintains Coterra Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTRA#NYSE">CTRA</a>) with a Buy and lowers the price target from $32 to $30.

CTRA

UBS Maintains Buy on Coterra Energy, Lowers Price Target to $30

UBS analyst Steven Fisher maintains Jacobs Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/J#NYSE">J</a>) with a Buy and lowers the price target from $154 to $152.

UBS Maintains Buy on Jacobs Solutions, Lowers Price Target to $152

UBS analyst Trung Huynh maintains Insmed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSM#NASDAQ">INSM</a>) with a Buy and lowers the price target from $110 to $109.

INSM

UBS Maintains Buy on Insmed, Lowers Price Target to $109

UBS analyst Peter Grom maintains Molson Coors Beverage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>) with a Neutral and lowers the price target from $63 to $59.

UBS Maintains Neutral on Molson Coors Beverage, Lowers Price Target to $59

UBS analyst Dan Leonard maintains Bio-Techne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TECH#NASDAQ">TECH</a>) with a Buy and lowers the price target from $95 to $70.

TECH

UBS Maintains Buy on Bio-Techne, Lowers Price Target to $70

UBS analyst John Lovallo maintains Trex Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TREX#NYSE">TREX</a>) with a Neutral and lowers the price target from $74 to $72.

TREX

UBS Maintains Neutral on Trex Co, Lowers Price Target to $72

UBS analyst Kevin Caliendo maintains Dentsply Sirona (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XRAY#NASDAQ">XRAY</a>) with a Buy and lowers the price target from $27 to $25.

XRAY

UBS Maintains Buy on Dentsply Sirona, Lowers Price Target to $25

UBS analyst Kunal Madhukar maintains ZipRecruiter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIP#NYSE">ZIP</a>) with a Neutral and lowers the price target from $7 to $6.

UBS Maintains Neutral on ZipRecruiter, Lowers Price Target to $6

UBS analyst Seth Gilbert maintains Veritone (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERI#NASDAQ">VERI</a>) with a Neutral and lowers the price target from $3.5 to $2.

VERI

UBS Maintains Neutral on Veritone, Lowers Price Target to $2

UBS analyst Danielle Antalffy maintains Treace Medical Concepts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMCI#NASDAQ">TMCI</a>) with a Neutral and lowers the price target from $10 to $8.6.

TMCI

UBS Maintains Neutral on Treace Medical Concepts, Lowers Price Target to $8.6

UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) has outperformed the market over the past 10 years by 2.1% on an annualized basis producing an average annual return of 12.37%. Currently, UnitedHealth Group has a market capitalization of $344.73 billion. 
Buying $1000 In UNH: If an investor had bought $1000 of UNH stock 10 years ago, it would be worth $3,285.34 today based on a price of $380.02 for UNH at the time of writing.
<h3>UnitedHealth Group's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746828911_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning UnitedHealth Group Stock In The Last 10 Years

UBS analyst Kevin Mcveigh maintains Rackspace Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXT#NASDAQ">RXT</a>) with a Neutral and lowers the price target from $2.95 to $1.9.

UBS Maintains Neutral on Rackspace Technology, Lowers Price Target to $1.9

UBS analyst Chris Zhang maintains International Money (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMXI#NASDAQ">IMXI</a>) with a Neutral and lowers the price target from $17 to $12.

Comments

BlackLine

뉴스

에 대한 최신 뉴스 BlackLine (NASDAQ:BL) 주식

금요일, 11월 15, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌